Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Fractional CO2 laser therapy effectively improves skin conditions and recovery when combined with other treatments.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Epidermal stem cells show promise for skin repair and regeneration.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Multiomics helps understand and improve skin healing and repair.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Exosomes could improve skin health and treat skin diseases, but more research is needed.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Precision medicine is crucial for early diagnosis and personalized treatment in prediabetes.

High-dose testosterone with finasteride improves muscle health in males with spinal cord injury.

Isotretinoin effectively treats severe acne but can affect blood and inflammation markers, posing risks for some people.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Loss of the Y chromosome in men is linked to health issues like heart disease and cancer.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

The U.S., China, and the U.K. lead Alzheimer's and white matter research.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Cellular senescence may play a role in ALS, and anti-senescence therapies could be a promising treatment.

Early diagnosis and personalized treatment of PCOS improve quality of life and prevent complications.

LTBP1 is a key regulator in diseases and a potential target for new treatments.